193 related articles for article (PubMed ID: 31042473)
1. Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation.
Sun D; Stopka-Farooqui U; Barry S; Aksoy E; Parsonage G; Vossenkämper A; Capasso M; Wan X; Norris S; Marshall JL; Clear A; Gribben J; MacDonald TT; Buckley CD; Korbonits M; Haworth O
Cell Rep; 2019 Apr; 27(5):1461-1471.e4. PubMed ID: 31042473
[TBL] [Abstract][Full Text] [Related]
2. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.
Duan S; Cermak L; Pagan JK; Rossi M; Martinengo C; di Celle PF; Chapuy B; Shipp M; Chiarle R; Pagano M
Nature; 2012 Jan; 481(7379):90-3. PubMed ID: 22113614
[TBL] [Abstract][Full Text] [Related]
3. Chronic psychological stress impairs germinal center response by repressing miR-155.
Sun W; Zhang L; Lin L; Wang W; Ge Y; Liu Y; Yang B; Hou J; Cheng X; Chen X; Wang Z
Brain Behav Immun; 2019 Feb; 76():48-60. PubMed ID: 30414952
[TBL] [Abstract][Full Text] [Related]
4. FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease.
Schneider C; Kon N; Amadori L; Shen Q; Schwartz FH; Tischler B; Bossennec M; Dominguez-Sola D; Bhagat G; Gu W; Basso K; Dalla-Favera R
Blood; 2016 Aug; 128(5):660-6. PubMed ID: 27166359
[TBL] [Abstract][Full Text] [Related]
5. IL4 and IL21 cooperate to induce the high Bcl6 protein level required for germinal center formation.
Chevrier S; Kratina T; Emslie D; Tarlinton DM; Corcoran LM
Immunol Cell Biol; 2017 Nov; 95(10):925-932. PubMed ID: 28875978
[TBL] [Abstract][Full Text] [Related]
6. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.
Lu X; Fernando TM; Lossos C; Yusufova N; Liu F; Fontán L; Durant M; Geng H; Melnick J; Luo Y; Vega F; Moy V; Inghirami G; Nimer S; Melnick AM; Lossos IS
Blood; 2018 Nov; 132(19):2026-2039. PubMed ID: 30082494
[TBL] [Abstract][Full Text] [Related]
7. Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation.
Yang X; Lee K; Said J; Gong X; Zhang K
Blood; 2006 Sep; 108(6):2006-12. PubMed ID: 16728698
[TBL] [Abstract][Full Text] [Related]
8. Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma.
Pighi C; Cheong TC; Compagno M; Patrucco E; Arigoni M; Olivero M; Wang Q; López C; Bernhart SH; Grande BM; Poggio T; Langellotto F; Bonello L; Dall'Olio R; Martínez-Martín S; Molinaro L; Francia di Celle P; Whitfield JR; Soucek L; Voena C; Calogero RA; Morin RD; Staudt LM; Siebert R; Zamò A; Chiarle R
Blood Adv; 2021 Dec; 5(23):5239-5257. PubMed ID: 34625792
[TBL] [Abstract][Full Text] [Related]
9. Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma.
van Engelen N; van Dijk F; Waanders E; Buijs A; Vermeulen MA; Loeffen JLC; Kuiper RP; Jongmans MCJ
Fam Cancer; 2021 Oct; 20(4):349-354. PubMed ID: 33811277
[TBL] [Abstract][Full Text] [Related]
10. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation.
Jaye DL; Iqbal J; Fujita N; Geigerman CM; Li S; Karanam S; Fu K; Weisenburger DD; Chan WC; Moreno CS; Wade PA
J Pathol; 2007 Sep; 213(1):106-15. PubMed ID: 17573669
[TBL] [Abstract][Full Text] [Related]
11. TOX expression in cutaneous B-cell lymphomas.
Schrader AM; Jansen PM; Willemze R
Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
[TBL] [Abstract][Full Text] [Related]
12. Histone Arginine Methylation by PRMT7 Controls Germinal Center Formation via Regulating Bcl6 Transcription.
Ying Z; Mei M; Zhang P; Liu C; He H; Gao F; Bao S
J Immunol; 2015 Aug; 195(4):1538-47. PubMed ID: 26179907
[TBL] [Abstract][Full Text] [Related]
13. BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2.
Ding J; Dirks WG; Ehrentraut S; Geffers R; MacLeod RA; Nagel S; Pommerenke C; Romani J; Scherr M; Vaas LA; Zaborski M; Drexler HG; Quentmeier H
Haematologica; 2015 Jun; 100(6):801-9. PubMed ID: 25769544
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
15. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.
Saito M; Gao J; Basso K; Kitagawa Y; Smith PM; Bhagat G; Pernis A; Pasqualucci L; Dalla-Favera R
Cancer Cell; 2007 Sep; 12(3):280-92. PubMed ID: 17785208
[TBL] [Abstract][Full Text] [Related]
16. Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations.
Hernández-Ramírez LC; Martucci F; Morgan RM; Trivellin G; Tilley D; Ramos-Guajardo N; Iacovazzo D; D'Acquisto F; Prodromou C; Korbonits M
J Clin Endocrinol Metab; 2016 Aug; 101(8):3144-54. PubMed ID: 27253664
[TBL] [Abstract][Full Text] [Related]
17. PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.
Franco R; Scognamiglio G; Valentino E; Vitiello M; Luciano A; Palma G; Arra C; La Mantia E; Panico L; Tenneriello V; Pinto A; Frigeri F; Capobianco G; Botti G; Cerchia L; De Chiara A; Fedele M
Oncotarget; 2016 Sep; 7(37):59158-59172. PubMed ID: 27494852
[TBL] [Abstract][Full Text] [Related]
18. External signals regulate germinal center fate-determining transcription factors in the A20 lymphoma cell line.
Feng J; Liu X; Ni X; Qi H
Mol Immunol; 2018 Jan; 93():79-86. PubMed ID: 29154209
[TBL] [Abstract][Full Text] [Related]
19. BCL6-Mediated Silencing of PD-1 Ligands in Germinal Center B Cells Maintains Follicular T Cell Population.
Peng C; Hu Q; Yang F; Zhang H; Li F; Huang C
J Immunol; 2019 Feb; 202(3):704-713. PubMed ID: 30567732
[TBL] [Abstract][Full Text] [Related]
20. BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma.
Saito M; Novak U; Piovan E; Basso K; Sumazin P; Schneider C; Crespo M; Shen Q; Bhagat G; Califano A; Chadburn A; Pasqualucci L; Dalla-Favera R
Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11294-9. PubMed ID: 19549844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]